Clinical features of COVID‐19 convalescent patients with re‐positive nucleic acid detection

Author:

Zhu Hui12ORCID,Fu Liyun23,Jin Yinhua4,Shao Jiale5,Zhang Shun12,Zheng Nanhong6,Fan Lingyan6,Yu Zhe5,Ying Jun5,Hu Yaoren23,Chen Tongen7,Chen Yanglingzi12,Chen Min12,Chen Mingjue12,Xiong Zi12,Kang Junfei12,Jin Jiachang12,Cai Ting12,Ye Honghua8

Affiliation:

1. Department of Experimental Medical ScienceHwaMei HospitalUniversity of Chinese Academy of Sciences Ningbo China

2. Key Laboratory of Diagnosis and Treatment of Digestive System Tumors of Zhejiang Province Ningbo China

3. Department of HepatologyHwaMei HospitalUniversity of Chinese Academy of Sciences Ningbo China

4. Department of RadiologyHwaMei HospitalUniversity of Chinese Academy of Sciences Ningbo China

5. Department of RespiratoryHwaMei HospitalUniversity of Chinese Academy of Sciences Ningbo China

6. Department of Acute InfectionHwaMei Hospital University of Chinese Academy of Sciences Ningbo China

7. Department of General practiceHwaMei HospitalUniversity of Chinese Academy of Sciences Ningbo China

8. Department of CardiologyHwaMei HospitalUniversity of Chinese Academy of Sciences Ningbo China

Publisher

Wiley

Subject

Microbiology (medical),Biochemistry, medical,Medical Laboratory Technology,Clinical Biochemistry,Public Health, Environmental and Occupational Health,Hematology,Immunology and Allergy

Reference20 articles.

1. International Committee on Taxonomy of Viruses.Naming the 2019 coronavirus.https://talk.ictvonline.org/. Accessed February 25 2020.

2. WHO Declares COVID‐19 a Pandemic;Cucinotta D;Acta Biomed,2020

3. World Health Organization.Coronavirus disease (COVID‐19) outbreak situation.https://www.who.int/emergencies/diseases/novel-coronavirus-2019. Accessed April 10 2020.

4. Novel coronavirus 2019‐nCoV: prevalence, biological and clinical characteristics comparison with SARS‐CoV and MERS‐CoV;Meo SA;Eur Rev Med Pharmacol Sci,2020

5. Case of the Index Patient Who Caused Tertiary Transmission of Coronavirus Disease 2019 in Korea: the Application of Lopinavir/Ritonavir for the Treatment of COVID-19 Pneumonia Monitored by Quantitative RT-PCR

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3